Broomfield, CO, December 17, 2016 --(PR.com
)-- MedAware Systems, Inc. announced today that Dr. Peter Nichol has joined the Company as its Chief Medical Officer. Dr. Nichol has served as Chair of the Company’s Scientific Advisory Board since 2015.
Dr. Nichol is a renowned surgeon and researcher. He is certified by the American Board of Surgery in General Surgery and Pediatric Surgery. Dr. Nichol specializes in minimally invasive surgery, including pediatric general surgery, pediatric thoracic surgery, minimally invasive pediatric surgery, and pediatric trauma surgery.
Dr. Nichol served as a principal investigator, or co-investigator, on numerous NIH funded research grants and is widely published in leading peer reviewed journals. His research is focused on pediatric nutrition and caring for children with congenital anomalies of the intestine.
“We are pleased to announce that Dr. Nichol is joining us as our Chief Medical Officer,” says Michael Willis, Chief Executive Officer for MedAware Systems. “Dr. Nichol has been, and remains, a passionate thought leader on the critical role medical evidence plays in creating optimal healthcare organizations. His ability to effectively connect and communicate with diverse segments in the healthcare industry will be instrumental as MedAware Systems expands its unique and powerful data services for Clinicians, Patients, Pharma and Medical Device Companies, and Payers,” he adds.
Dr. Nichol is a graduate of the Washington University School of Medicine, St. Louis, MO. Prior to joining the faculty at the University of Wisconsin School of Medicine and Public Health, he was an Assistant Professor and Research Fellow at Children’s Health Research Center, University of Utah, and a Staff Surgeon and Pediatric Surgery Fellow at Children's Hospital of Philadelphia, Philadelphia, PA.
About MedAware Systems, Inc.
MedAware Systems, Inc. disrupts the health informatics industry by forever changing the way physicians, researchers, payers and consumers derive usable, accurate evidence from published clinical trials research. The Company is continuously populating its industry leading database with all available medical research information. These data are extracted, normalized and standardized using the Companies patent-pending software and methodologies to provide highly accurate search and retrieval of evidence-based medical treatments and outcomes. With data precisely filtered by patient profile and disease profile, customers receive the most comprehensive, accurate, and granular meta-analysis of medical research data available today.